Genmab Rises 2% as Earnings Beat Confirms Growth Engine, Analysts Say

(PLX AI) – Genmab shares rose 2% in early trading as earnings after the market yesterday beat consensus on revenue and EBIT. Revenue was 3% ahead and EBIT was 6% ahead of company-compiled estimatesOutlook for 2022 was also better than expected, with …